What is the recommended dosage of aspirin (acetylsalicylic acid) for adults?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Dosage of Aspirin for Adults

The recommended dosage of aspirin for adults is 75-162 mg daily for cardiovascular prevention, with 81 mg being the most commonly prescribed dose in the United States as it provides effective cardiovascular benefits while minimizing bleeding risk. 1

Dosage Guidelines by Clinical Scenario

Primary Prevention

  • For adults aged 50-59 years with ≥10% 10-year cardiovascular risk and low bleeding risk, 75-162 mg/day is recommended 1
  • For adults aged 60-69 years, aspirin may be considered at 75-162 mg/day, but with smaller net benefit due to increased bleeding risk 1
  • Not recommended for adults <50 years with low cardiovascular risk due to unfavorable benefit-risk ratio 1
  • Not generally recommended for adults >70 years as bleeding risks typically outweigh benefits 1

Secondary Prevention

  • For patients with established atherosclerotic cardiovascular disease (ASCVD), 75-162 mg/day is strongly recommended 1
  • For acute coronary syndrome, a loading dose of 162-325 mg followed by 75-100 mg daily maintenance dose 2
  • For patients with documented aspirin allergy, clopidogrel 75 mg/day should be used 1

Dosing Considerations

Optimal Dose Selection

  • The lowest effective dose (75-100 mg daily) should be used to minimize gastrointestinal bleeding risk 3
  • 81 mg daily is the most common low-dose tablet in the US and is generally sufficient for cardiovascular protection 1
  • Clinical trials have used doses ranging from 50-650 mg daily, but most evidence supports 75-162 mg daily 1, 4
  • The ADAPTABLE trial showed no significant differences in cardiovascular events or major bleeding between 81 mg and 325 mg daily doses in patients with established cardiovascular disease 1

Special Populations

  • In diabetic patients, 75-162 mg/day may be considered for primary prevention in those with high cardiovascular risk and low bleeding risk 1
  • Dual antiplatelet therapy (aspirin plus P2Y12 inhibitor) is recommended for 1 year after acute coronary syndrome 1, 2
  • Aspirin is contraindicated in patients <21 years due to risk of Reye syndrome 1

Safety Considerations

Bleeding Risk

  • Major bleeding risk increases with aspirin use, from 3.2% to 4.1% in primary prevention studies 1
  • Gastrointestinal bleeding risk may be as high as 5 per 1,000 person-years in real-world settings 1, 2
  • Risk factors for bleeding include older age, history of GI bleeding, concurrent NSAID or anticoagulant use, and uncontrolled hypertension 2

Risk-Benefit Assessment

  • For patients with >1% annual ASCVD risk, the number of cardiovascular events prevented is similar to or greater than bleeding events induced 1, 2
  • Benefit-risk ratio is most favorable in secondary prevention 1
  • Shared decision-making is important, especially in primary prevention scenarios 1

Administration

  • Aspirin should be taken with a full glass of water 5
  • Non-enteric coated aspirin should be chewed when possible for rapid onset of antiplatelet action in acute settings 2
  • Daily administration is preferred over alternate-day dosing for cardiovascular prevention 6

Remember that while FDA-approved analgesic dosing may be higher (up to 4-8 tablets every 4 hours), cardiovascular prevention requires much lower doses to optimize the benefit-risk ratio 5, 3.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Aspirina en el Manejo Médico Cardiovascular

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Gastrointestinal safety of low-dose aspirin.

The American journal of managed care, 2002

Research

Aspirin in cardiovascular disorders. What is the optimum dose?

American journal of cardiovascular drugs : drugs, devices, and other interventions, 2004

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.